Skip to main content
44°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
99
100
Next >
FDA Expands Approval For Bristol Myers Squibb's Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies
May 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
May 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MRNA
Tesla Recalls 2024: More Than 125,000 Vehicles Recalled for Seatbelt Issues
May 31, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
NVOS
TSLA
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
GSK
MRNA
PFE
First in the world Sungen Biomedical obtains FDA’s clinical trial approval of IND SGC001 as an emergency use antibody drug for AMI
May 31, 2024
Via
Get News
Topics
Death
Exposures
Death
Product Safety
REMSleep Holdings Shareholder Update
May 29, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
RMSL
Woman-Owned Small Family Business, Academic Entertainment, Transitions Leadership to the Second Generation
May 24, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
US Eco-Friendly Direct Thermal Labels for Prepared Food Packaging Announced
May 24, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
REGN
SNY
BREAKING: Tesla Recalls Over 125,000 Cars To Fix Faulty Seat Belt Warnings
May 31, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
May 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
May 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AMGN
AZN
REMSleep Holdings Shareholder Update
May 29, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
RMSL
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
May 29, 2024
Via
News Direct
Exposures
Product Safety
Tickers
IOVA
OTLC
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
LLY
MRNA
PFE
PRME
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
May 28, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
PFE
RY
SRPT
TSX:RY
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8® in ALS
May 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
May 28, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AGIO
RPRX
The Sandbox’s Journey from Mobile Gaming to a Leading Web3 Platform with Sebastien Borget
May 28, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Compumedics set for record-breaking $46 million FY24 revenue
May 27, 2024
Via
News Direct
Exposures
Product Safety
Tickers
ASX:CMP
BLUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 27, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
Compumedics set for record-breaking $46 million FY24 revenue
May 27, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
ASX:CMP
BLUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 27, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
Ken’s Hardwood Barbecue Hosts Watch Party for Pat Sajak’s Farewell on Wheel of Fortune
May 24, 2024
Via
Get News
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GH
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
EXAS
GH
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
May 24, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AMGN
BMY
VSTM
BLUE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 23, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
BLUE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
May 23, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
CCHR Commends Lawsuit Filed over FDA’s Failure to Act on Citizen Petition to Update Antidepressant Labeling for Persistent Sexual Problems
May 22, 2024
Via
Press Release Distribution Service
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.